Search
for
Sort by
Research 211–240 of 540
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment
- Association between Insulin Resistance and Hyperandrogenism among Women with PCOS in Pakistan
- Association Between Insulin Resistance and Hyperandrogenism in Women with PCOS. A Cross-Sectional Clinical Study
- POLİKİSTİK OVER SENDROMU FENOTİPLERİ VE METABOLİK DİSFONKSİYON İLİŞKİSİ
- Idiopathic unilateral facial hirsutism
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Extraskeletal actions of vitamin D
- High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Cardiometabolic profile of young women with hypoprolactinemia
- PCOS in Adolescence and Type 2 Diabetes
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent